Clearly, discriminatory capacities of conventional LT selection models may be substantially improved by incorporating clinical surrogates of tumor biology, such as serum alfa-fetoprotein (AFP) [2], responses to locoregional treatments [3] and metabolic uptake patterns on 18F-fluorodeoxy-glucose (FDG) positron emission tomography (PET) [4]. Here, AFP is linked to neoplasm.